Unibest
← Back to patent-cliff list

Clazosentan Sodium

Tier C — Watch / trade

Clazosentan Sodium

F. Hoffmann-La Roche
Originator
2022
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type

Targets:ETAR

Brand:Pivlaz

Indications (approved):动脉瘤, Intracranial vasospasm, Subarachnoid haemorrhage, Cerebral infarction, 脑缺血

Regional status

US
Phase III
2007-12-14
EU
Phase III
2007-12-14
China
No progress
2007-12-14
Japan
Approved
2022-01-20

Synthetic routes & intermediates1 routes

Originator routes × 1Optimised (non-patent) × 0Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 8 · Total yield /
CLAZ-001100-48-1CLAZ-0026345-27-3CLAZ-003150726-89-9CLAZ-004150728-08-8CLAZ-005150727-72-3CLAZ-006180385-16-4CLAZ-007197448-77-4CLAZ-008180385-42-6CLAZ-009180384-43-4CLAZ-010180385-03-9API · Clazosentan Sodium
CodeCAS No.Intermediate
CLAZ-001100-48-1isonicotinonitrile
CLAZ-0026345-27-3isonicotinimidamide hydrochloride
CLAZ-003150726-89-9dimethyl 2-(2-methoxyphenoxy)malonate
CLAZ-004150728-08-85-(2-methoxyphenoxy)-2-(pyridin-4-yl)pyrimidine-4,6-diol
CLAZ-005150727-72-34,6-dichloro-5-(2-methoxyphenoxy)-2-(pyridin-4-yl)pyrimidine
CLAZ-006180385-16-44-(4,6-dichloro-5-(2-methoxyphenoxy)pyrimidin-2-yl)pyridine 1-oxide
CLAZ-007197448-77-4potassium ((5-methylpyridin-2-yl)sulfonyl)amide
CLAZ-008180385-42-64-(4-chloro-5-(2-methoxyphenoxy)-6-((5-methylpyridine)-2-sulfonamido)pyrimidin-2-yl)pyridine 1-oxide
CLAZ-009180384-43-44-(4-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-6-((5-methylpyridine)-2-sulfonamido)pyrimidin-2-yl)pyridine 1-oxide
CLAZ-010180385-03-9N-(2-(2-cyanopyridin-4-yl)-6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)pyrimidin-4-yl)-5-methylpyridine-2-sulfonamide

Frequently asked questions

What are the approved indications of Clazosentan Sodium?

Approved indications include: 动脉瘤, Intracranial vasospasm, Subarachnoid haemorrhage, Cerebral infarction, 脑缺血.

When does the Clazosentan Sodium patent expire?

No public expiry year is available for Clazosentan Sodium yet; this page updates once verified.

How many synthesis routes are recorded for Clazosentan Sodium?

1 synthesis routes are recorded; the shortest is 8 steps with / total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Clazosentan Sodium intermediates?

All intermediates in Clazosentan Sodium routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.

How do I get a quote for Clazosentan Sodium intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-27